Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (31-40 of 6,821) with videos related to

Pageof 683
Sort By:
Nature|June 26, 2024
These 3D model brains with cells from several people are first of their kindAsher Mullard
Scientific American|July 18, 2024
The Human ThirstAsher Rosinger
Nature Reviews. Drug Discovery|July 18, 2024
Eli Lilly spends $3.2 billion on Morphic's oral integrin inhibitor for inflammatory bowel diseaseAsher Mullard
Nature Reviews. Drug Discovery|January 28, 2026
Hunting for biopharma's innovation sweet spotAsher Mullard
Nature Reviews. Drug Discovery|May 7, 2025
FDA approves J&J's FcRn blocker for generalized myasthenia gravisAsher Mullard
Nursing Mirror|November 30, 1983
Working towards priorities. Interview by Alison MortonC Asher
Nature Reviews. Drug Discovery|June 10, 2025
FDA approves first-in-class TRPM8 ion channel agonist for dry eye diseaseAsher Mullard
Nature Reviews. Drug Discovery|June 10, 2025
FDA approves a c-MET-targeted ADC for lung cancerAsher Mullard
The American Journal of Psychiatry|March 1, 1971
"Trailing" phenomenon--a long-lasting LSD side effectH Asher
Nature Reviews. Drug Discovery|February 2, 2011
2010 FDA drug approvalsAsher Mullard
Pageof 683

Showing results (31-40 of 6,821) with videos related to

Sort By:
Pageof 683
Nature|June 26, 2024
These 3D model brains with cells from several people are first of their kindAsher Mullard
Scientific American|July 18, 2024
The Human ThirstAsher Rosinger
Nature Reviews. Drug Discovery|July 18, 2024
Eli Lilly spends $3.2 billion on Morphic's oral integrin inhibitor for inflammatory bowel diseaseAsher Mullard
Nature Reviews. Drug Discovery|January 28, 2026
Hunting for biopharma's innovation sweet spotAsher Mullard
Nature Reviews. Drug Discovery|May 7, 2025
FDA approves J&J's FcRn blocker for generalized myasthenia gravisAsher Mullard
Nursing Mirror|November 30, 1983
Working towards priorities. Interview by Alison MortonC Asher
Nature Reviews. Drug Discovery|June 10, 2025
FDA approves first-in-class TRPM8 ion channel agonist for dry eye diseaseAsher Mullard
Nature Reviews. Drug Discovery|June 10, 2025
FDA approves a c-MET-targeted ADC for lung cancerAsher Mullard
The American Journal of Psychiatry|March 1, 1971
"Trailing" phenomenon--a long-lasting LSD side effectH Asher
Nature Reviews. Drug Discovery|February 2, 2011
2010 FDA drug approvalsAsher Mullard
Pageof 683